1,2-dimethylhydrazine decreases expression ISO RGD:1319650 6480464 1, 2-Dimethylhydrazine results in decreased expression of HIPK2 mRNA CTD PMID:22206623 1-chloro-2,4-dinitrobenzene increases expression ISO RGD:1319649 6480464 Dinitrochlorobenzene results in increased expression of HIPK2 mRNA CTD PMID:16314067 17alpha-ethynylestradiol increases expression EXP 6480464 Ethinyl Estradiol results in increased expression of HIPK2 mRNA CTD PMID:29097150 17beta-estradiol increases expression ISO RGD:1319650 6480464 Estradiol results in increased expression of HIPK2 mRNA CTD PMID:25210133 17beta-estradiol decreases expression ISO RGD:1319649 6480464 Estradiol results in decreased expression of HIPK2 mRNA CTD PMID:21185374 17beta-estradiol increases expression ISO RGD:1319649 6480464 Estradiol results in increased expression of HIPK2 mRNA CTD PMID:23019147 more ... 17beta-estradiol multiple interactions ISO RGD:1319649 6480464 [Estradiol co-treated with Progesterone] results in decreased expression of HIPK2 mRNA, EGF protein promotes the reaction [Estradiol results in increased expression of HIPK2 mRNA] CTD PMID:20660070 , PMID:24758408 17beta-hydroxy-5alpha-androstan-3-one increases expression ISO RGD:1319649 6480464 Dihydrotestosterone results in increased expression of HIPK2 mRNA CTD PMID:29581250 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1319650 6480464 Tetrachlorodibenzodioxin results in increased expression of HIPK2 mRNA CTD PMID:17035482 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of HIPK2 mRNA CTD PMID:33387578 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of HIPK2 mRNA CTD PMID:32109520 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1319649 6480464 Tetrachlorodibenzodioxin results in increased expression of HIPK2 mRNA CTD PMID:29704546 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1319649 6480464 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of HIPK2 mRNA] CTD PMID:29704546 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1319650 6480464 Tetrachlorodibenzodioxin affects the expression of HIPK2 mRNA CTD PMID:28922406 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1319649 6480464 Tetrachlorodibenzodioxin affects the expression of HIPK2 mRNA CTD PMID:22574217 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of HIPK2 mRNA CTD PMID:22298810 , PMID:34747641 2,3,7,8-Tetrachlorodibenzofuran decreases expression EXP 6480464 2 more ... CTD PMID:32109520 2,6-dinitrotoluene affects expression EXP 6480464 2, 6-dinitrotoluene affects the expression of HIPK2 mRNA CTD PMID:21346803 2-butoxyethanol increases expression ISO RGD:1319650 6480464 n-butoxyethanol results in increased expression of HIPK2 mRNA CTD PMID:19812364 3,3',4,4',5-pentachlorobiphenyl increases expression ISO RGD:1319649 6480464 3 more ... CTD PMID:23146750 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:1319649 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of HIPK2 mRNA more ... CTD PMID:28628672 3-methylcholanthrene decreases expression ISO RGD:1319650 6480464 Methylcholanthrene results in decreased expression of HIPK2 mRNA CTD PMID:20713471 3-Nitrobenzanthrone increases expression ISO RGD:1319649 6480464 3-nitrobenzanthrone results in increased expression of HIPK2 mRNA CTD PMID:34036453 4,4'-diaminodiphenylmethane decreases expression ISO RGD:1319650 6480464 4, 4'-diaminodiphenylmethane results in decreased expression of HIPK2 mRNA CTD PMID:18648102 4,4'-sulfonyldiphenol multiple interactions ISO RGD:1319649 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of HIPK2 mRNA CTD PMID:28628672 4,4'-sulfonyldiphenol multiple interactions EXP 6480464 [bisphenol A co-treated with bisphenol F co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of HIPK2 mRNA CTD PMID:36041667 4-\{[(5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)carbonyl]amino\}benzoic acid increases expression ISO RGD:1319649 6480464 Am 580 results in increased expression of HIPK2 mRNA CTD PMID:16982809 4-hydroxyphenyl retinamide decreases expression ISO RGD:1319650 6480464 Fenretinide results in decreased expression of HIPK2 mRNA CTD PMID:28973697 4-vinylcyclohexene dioxide affects expression ISO RGD:1319650 6480464 4-vinyl-1-cyclohexene dioxide affects the expression of HIPK2 mRNA CTD PMID:20829426 acrolein multiple interactions ISO RGD:1319649 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of HIPK2 mRNA, [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of HIPK2 mRNA CTD PMID:32699268 acrylamide decreases expression EXP 6480464 Acrylamide results in decreased expression of HIPK2 mRNA CTD PMID:28959563 aflatoxin B1 decreases methylation ISO RGD:1319649 6480464 Aflatoxin B1 results in decreased methylation of HIPK2 gene CTD PMID:27153756 aflatoxin B1 decreases expression EXP 6480464 Aflatoxin B1 results in decreased expression of HIPK2 mRNA CTD PMID:33354967 aflatoxin B1 increases methylation ISO RGD:1319649 6480464 Aflatoxin B1 results in increased methylation of HIPK2 intron CTD PMID:30157460 all-trans-retinoic acid increases expression ISO RGD:1319649 6480464 Tretinoin results in increased expression of HIPK2 mRNA CTD PMID:23830798 , PMID:33167477 alpha-pinene multiple interactions ISO RGD:1319649 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of HIPK2 mRNA, [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of HIPK2 mRNA CTD PMID:32699268 aristolochic acid A decreases expression ISO RGD:1319649 6480464 aristolochic acid I results in decreased expression of HIPK2 mRNA CTD PMID:33212167 arsane multiple interactions ISO RGD:1319649 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in increased expression of HIPK2 mRNA CTD PMID:32525701 arsenic atom multiple interactions ISO RGD:1319649 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in increased expression of HIPK2 mRNA CTD PMID:32525701 arsenite(3-) multiple interactions ISO RGD:1319649 6480464 arsenite inhibits the reaction [G3BP1 protein binds to HIPK2 mRNA] CTD PMID:32406909 atrazine decreases expression ISO RGD:1319649 6480464 Atrazine results in decreased expression of HIPK2 mRNA CTD PMID:22378314 benzo[a]pyrene increases expression ISO RGD:1319649 6480464 Benzo(a)pyrene results in increased expression of HIPK2 mRNA CTD PMID:20106945 benzo[a]pyrene decreases expression ISO RGD:1319650 6480464 Benzo(a)pyrene results in decreased expression of HIPK2 mRNA CTD PMID:19770486 , PMID:22228805 benzo[a]pyrene diol epoxide I decreases expression ISO RGD:1319649 6480464 7 more ... CTD PMID:19150397 benzo[e]pyrene decreases methylation ISO RGD:1319649 6480464 benzo(e)pyrene results in decreased methylation of HIPK2 intron CTD PMID:30157460 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of HIPK2 mRNA CTD PMID:25181051 , PMID:30816183 bisphenol A multiple interactions EXP 6480464 [bisphenol A co-treated with bisphenol F co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of HIPK2 mRNA CTD PMID:36041667 bisphenol A decreases methylation ISO RGD:1319649 6480464 bisphenol A results in decreased methylation of HIPK2 gene CTD PMID:31601247 bisphenol A decreases expression ISO RGD:1319650 6480464 bisphenol A results in decreased expression of HIPK2 mRNA CTD PMID:33221593 bisphenol A increases expression ISO RGD:1319649 6480464 bisphenol A results in increased expression of HIPK2 mRNA CTD PMID:29275510 bisphenol A multiple interactions ISO RGD:1319649 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of HIPK2 mRNA CTD PMID:28628672 bisphenol A increases methylation EXP 6480464 bisphenol A results in increased methylation of HIPK2 gene CTD PMID:28505145 bisphenol F multiple interactions ISO RGD:1319649 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of HIPK2 mRNA CTD PMID:28628672 bisphenol F multiple interactions EXP 6480464 [bisphenol A co-treated with bisphenol F co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of HIPK2 mRNA CTD PMID:36041667 buta-1,3-diene decreases expression ISO RGD:1319650 6480464 1, 3-butadiene results in decreased expression of HIPK2 mRNA CTD PMID:29038090 butanal decreases expression ISO RGD:1319649 6480464 butyraldehyde results in decreased expression of HIPK2 mRNA CTD PMID:26079696 cadmium atom increases expression ISO RGD:1319649 6480464 Cadmium results in increased expression of HIPK2 mRNA CTD PMID:24376830 cadmium atom multiple interactions ISO RGD:1319649 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of HIPK2 mRNA CTD PMID:35301059 cadmium dichloride multiple interactions ISO RGD:1319649 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of HIPK2 mRNA CTD PMID:35301059 calcitriol multiple interactions ISO RGD:1319649 6480464 [Testosterone co-treated with Calcitriol] results in increased expression of HIPK2 mRNA CTD PMID:21592394 calcitriol increases expression ISO RGD:1319649 6480464 Calcitriol results in increased expression of HIPK2 mRNA CTD PMID:21592394 carbon nanotube increases expression ISO RGD:1319650 6480464 Nanotubes more ... CTD PMID:25554681 CGP 52608 multiple interactions ISO RGD:1319649 6480464 CGP 52608 promotes the reaction [RORA protein binds to HIPK2 gene] CTD PMID:28238834 choline multiple interactions ISO RGD:1319650 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of and results in increased expression of HIPK2 more ... CTD PMID:20938992 cisplatin increases activity ISO RGD:1319649 6480464 Cisplatin results in increased activity of HIPK2 protein CTD PMID:20573984 cobalt dichloride multiple interactions ISO RGD:1319649 6480464 benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [cobaltous chloride results in decreased expression of HIPK2 protein] more ... CTD PMID:19128456 , PMID:19714248 cobalt dichloride decreases expression ISO RGD:1319649 6480464 cobaltous chloride results in decreased expression of HIPK2 protein CTD PMID:19714248 copper(II) sulfate decreases expression ISO RGD:1319649 6480464 Copper Sulfate results in decreased expression of HIPK2 mRNA CTD PMID:19549813 coumestrol decreases expression ISO RGD:1319649 6480464 Coumestrol results in decreased expression of HIPK2 mRNA CTD PMID:19167446 crotonaldehyde decreases expression ISO RGD:1319649 6480464 2-butenal results in decreased expression of HIPK2 mRNA CTD PMID:20471460 cyclosporin A decreases expression EXP 6480464 Cyclosporine results in decreased expression of HIPK2 mRNA CTD PMID:21865292 cyclosporin A decreases expression ISO RGD:1319649 6480464 Cyclosporine results in decreased expression of HIPK2 mRNA CTD PMID:25562108 dexamethasone multiple interactions ISO RGD:1319649 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of HIPK2 mRNA more ... CTD PMID:28628672 dibutyl phthalate decreases expression EXP 6480464 Dibutyl Phthalate results in decreased expression of HIPK2 mRNA CTD PMID:21266533 dicrotophos increases expression ISO RGD:1319649 6480464 dicrotophos results in increased expression of HIPK2 mRNA CTD PMID:28302478 diethylstilbestrol decreases expression ISO RGD:1319650 6480464 Diethylstilbestrol results in decreased expression of HIPK2 mRNA CTD PMID:22467019 dioxygen decreases expression ISO RGD:1319649 6480464 Oxygen deficiency results in decreased expression of HIPK2 protein CTD PMID:19714248 dioxygen increases expression ISO RGD:1319650 6480464 Oxygen deficiency results in increased expression of HIPK2 mRNA CTD PMID:22629407 dioxygen multiple interactions ISO RGD:1319650 6480464 [Oxygen deficiency co-treated with Oxygen] results in increased expression of HIPK2 mRNA more ... CTD PMID:22629407 , PMID:31837296 dioxygen multiple interactions ISO RGD:1319649 6480464 zinc chloride inhibits the reaction [Oxygen deficiency results in decreased expression of HIPK2 protein] CTD PMID:19714248 disodium selenite decreases expression ISO RGD:1319649 6480464 Sodium Selenite results in decreased expression of HIPK2 mRNA CTD PMID:18175754 doxorubicin multiple interactions ISO RGD:1319649 6480464 cobaltous chloride inhibits the reaction [Doxorubicin promotes the reaction [HIPK2 protein binds to HIF1A promoter]] more ... CTD PMID:19128456 , PMID:19714248 doxorubicin increases expression ISO RGD:1319650 6480464 Doxorubicin results in increased expression of HIPK2 mRNA, Doxorubicin results in increased expression of HIPK2 protein CTD PMID:28318631 doxorubicin decreases expression ISO RGD:1319649 6480464 Doxorubicin results in decreased expression of HIPK2 mRNA CTD PMID:29803840 doxorubicin multiple interactions ISO RGD:1319650 6480464 [Doxorubicin co-treated with zinc chloride] results in increased expression of HIPK2 mRNA more ... CTD PMID:19714248 more ... doxorubicin increases response to substance ISO RGD:1319649 6480464 HIPK2 protein results in increased susceptibility to Doxorubicin CTD PMID:19128456 elemental selenium multiple interactions ISO RGD:1319649 6480464 [Selenium co-treated with Vitamin E] results in decreased expression of HIPK2 mRNA CTD PMID:19244175 elemental selenium decreases expression ISO RGD:1319649 6480464 Selenium results in decreased expression of HIPK2 mRNA CTD PMID:19244175 endosulfan decreases expression EXP 6480464 Endosulfan results in decreased expression of HIPK2 mRNA CTD PMID:29391264 ethanol decreases expression ISO RGD:1319650 6480464 Ethanol results in decreased expression of HIPK2 mRNA CTD PMID:29018328 ethanol increases expression ISO RGD:1319650 6480464 Ethanol results in increased expression of HIPK2 mRNA CTD PMID:30319688 etoposide increases activity ISO RGD:1319649 6480464 Etoposide results in increased activity of HIPK2 protein CTD PMID:20573984 etoposide multiple interactions ISO RGD:1319650 6480464 HIPK2 gene mutant form inhibits the reaction [Etoposide results in increased expression of and results in increased phosphorylation of CREB1 protein] more ... CTD PMID:20573984 , PMID:20980392 etoposide decreases response to substance ISO RGD:1319650 6480464 HIPK2 results in decreased susceptibility to Etoposide CTD PMID:20573984 etoposide multiple interactions ISO RGD:1319649 6480464 HIPK2 mutant form inhibits the reaction [Etoposide results in increased expression of BDNF mRNA] CTD PMID:20573984 folic acid multiple interactions ISO RGD:1319650 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of and results in increased expression of HIPK2 more ... CTD PMID:20938992 formaldehyde decreases expression ISO RGD:1319649 6480464 Formaldehyde results in decreased expression of HIPK2 mRNA CTD PMID:23649840 gentamycin decreases expression EXP 6480464 Gentamicins results in decreased expression of HIPK2 mRNA CTD PMID:33387578 glafenine decreases expression EXP 6480464 Glafenine results in decreased expression of HIPK2 mRNA CTD PMID:24136188 heptachlor decreases expression EXP 6480464 Heptachlor results in decreased expression of HIPK2 mRNA CTD PMID:23153324 hypochlorous acid increases expression ISO RGD:1319650 6480464 Hypochlorous Acid results in increased expression of HIPK2 mRNA CTD PMID:19376150 indometacin multiple interactions ISO RGD:1319649 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of HIPK2 mRNA more ... CTD PMID:28628672 isoprenaline decreases expression ISO RGD:1319650 6480464 Isoproterenol results in decreased expression of HIPK2 mRNA CTD PMID:20003209 L-methionine multiple interactions ISO RGD:1319650 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of and results in increased expression of HIPK2 more ... CTD PMID:20938992 menadione affects expression ISO RGD:1319649 6480464 Vitamin K 3 affects the expression of HIPK2 mRNA CTD PMID:20044591 methapyrilene decreases expression EXP 6480464 Methapyrilene results in decreased expression of HIPK2 mRNA CTD PMID:30467583 methapyrilene decreases methylation ISO RGD:1319649 6480464 Methapyrilene results in decreased methylation of HIPK2 intron CTD PMID:30157460 methoxychlor affects expression ISO RGD:1319650 6480464 Methoxychlor affects the expression of HIPK2 mRNA CTD PMID:20829426 methyl methanesulfonate decreases expression ISO RGD:1319649 6480464 Methyl Methanesulfonate results in decreased expression of HIPK2 mRNA CTD PMID:23649840 Monobutylphthalate affects expression EXP 6480464 monobutyl phthalate affects the expression of HIPK2 mRNA CTD PMID:20864626 N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal multiple interactions ISO RGD:1319649 6480464 benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [cobaltous chloride results in decreased expression of HIPK2 protein] CTD PMID:19714248 nickel sulfate increases expression ISO RGD:1319649 6480464 nickel sulfate results in increased expression of HIPK2 mRNA CTD PMID:16314067 niclosamide multiple interactions ISO RGD:1319650 6480464 Niclosamide inhibits the reaction [Doxorubicin results in increased expression of HIPK2 mRNA], Niclosamide inhibits the reaction [Doxorubicin results in increased expression of HIPK2 protein] CTD PMID:28318631 niclosamide multiple interactions ISO RGD:1319649 6480464 HIPK2 protein inhibits the reaction [Niclosamide inhibits the reaction [TGFB1 protein results in increased expression of FN1 mRNA]] more ... CTD PMID:28318631 niclosamide multiple interactions EXP 6480464 Niclosamide inhibits the reaction [TGFB1 protein results in increased expression of HIPK2 mRNA], Niclosamide inhibits the reaction [TGFB1 protein results in increased expression of HIPK2 protein] CTD PMID:28318631 ozone multiple interactions ISO RGD:1319649 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of HIPK2 mRNA more ... CTD PMID:32699268 paracetamol affects expression ISO RGD:1319650 6480464 Acetaminophen affects the expression of HIPK2 mRNA CTD PMID:17562736 paracetamol decreases expression EXP 6480464 Acetaminophen results in decreased expression of HIPK2 mRNA CTD PMID:33387578 paracetamol decreases expression ISO RGD:1319649 6480464 Acetaminophen results in decreased expression of HIPK2 mRNA CTD PMID:21420995 pentachlorophenol increases expression ISO RGD:1319650 6480464 Pentachlorophenol results in increased expression of HIPK2 mRNA CTD PMID:23892564 phenobarbital decreases expression ISO RGD:1319650 6480464 Phenobarbital results in decreased expression of HIPK2 mRNA CTD PMID:23091169 phosgene affects expression ISO RGD:1319650 6480464 Phosgene affects the expression of HIPK2 mRNA CTD PMID:16300373 pirinixic acid decreases expression ISO RGD:1319650 6480464 pirinixic acid results in decreased expression of HIPK2 mRNA CTD PMID:18445702 pirinixic acid increases expression EXP 6480464 pirinixic acid results in increased expression of HIPK2 mRNA CTD PMID:22484513 pirinixic acid increases expression ISO RGD:1319650 6480464 pirinixic acid results in increased expression of HIPK2 mRNA CTD PMID:18301758 progesterone decreases expression ISO RGD:1319649 6480464 Progesterone results in decreased expression of HIPK2 mRNA CTD PMID:18070364 progesterone multiple interactions ISO RGD:1319649 6480464 [Estradiol co-treated with Progesterone] results in decreased expression of HIPK2 mRNA CTD PMID:20660070 resveratrol decreases expression ISO RGD:1319650 6480464 resveratrol results in decreased expression of HIPK2 mRNA CTD PMID:23525482 rotenone increases expression EXP 6480464 Rotenone results in increased expression of HIPK2 mRNA CTD PMID:28374803 sarin increases expression ISO RGD:1319649 6480464 Sarin results in increased expression of HIPK2 mRNA CTD PMID:19522546 selenium atom multiple interactions ISO RGD:1319649 6480464 [Selenium co-treated with Vitamin E] results in decreased expression of HIPK2 mRNA CTD PMID:19244175 selenium atom decreases expression ISO RGD:1319649 6480464 Selenium results in decreased expression of HIPK2 mRNA CTD PMID:19244175 serpentine asbestos decreases methylation ISO RGD:1319649 6480464 Asbestos, Serpentine results in decreased methylation of HIPK2 3' UTR CTD PMID:29523930 silicon dioxide decreases expression ISO RGD:1319650 6480464 Silicon Dioxide results in decreased expression of HIPK2 mRNA CTD PMID:23221170 silver atom decreases expression ISO RGD:1319650 6480464 Silver results in decreased expression of HIPK2 mRNA CTD PMID:27131904 silver(0) decreases expression ISO RGD:1319650 6480464 Silver results in decreased expression of HIPK2 mRNA CTD PMID:27131904 sodium arsenate decreases expression ISO RGD:1319650 6480464 sodium arsenate results in decreased expression of HIPK2 mRNA CTD PMID:21795629 sodium arsenate multiple interactions ISO RGD:1319649 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in increased expression of HIPK2 mRNA CTD PMID:32525701 sodium arsenate increases expression ISO RGD:1319650 6480464 sodium arsenate results in increased expression of HIPK2 mRNA CTD PMID:21795629 sodium arsenite multiple interactions ISO RGD:1319649 6480464 [sodium arsenite results in increased stability of and affects the localization of HIPK2 protein] which results in increased phosphorylation of CREB1 protein, sodium arsenite results in increased stability of and affects the localization of HIPK2 protein CTD PMID:27884605 sodium arsenite affects expression ISO RGD:1319649 6480464 sodium arsenite affects the expression of HIPK2 mRNA CTD PMID:34032870 sodium arsenite multiple interactions ISO RGD:1319650 6480464 HIPK2 protein promotes the reaction [sodium arsenite results in increased expression of FTH1 mRNA] CTD PMID:20980392 sunitinib decreases expression ISO RGD:1319649 6480464 Sunitinib results in decreased expression of HIPK2 mRNA CTD PMID:31533062 temozolomide decreases expression ISO RGD:1319649 6480464 Temozolomide results in decreased expression of HIPK2 mRNA CTD PMID:31758290 testosterone multiple interactions ISO RGD:1319649 6480464 [Testosterone co-treated with Calcitriol] results in increased expression of HIPK2 mRNA CTD PMID:21592394 testosterone increases expression ISO RGD:1319649 6480464 Testosterone results in increased expression of HIPK2 mRNA CTD PMID:21592394 tetrachloromethane affects expression ISO RGD:1319650 6480464 Carbon Tetrachloride affects the expression of HIPK2 mRNA CTD PMID:17484886 thimerosal decreases expression ISO RGD:1319649 6480464 Thimerosal results in decreased expression of HIPK2 mRNA CTD PMID:27188386 torcetrapib increases expression ISO RGD:1319649 6480464 torcetrapib results in increased expression of HIPK2 mRNA CTD PMID:23228038 trichostatin A decreases expression ISO RGD:1319649 6480464 trichostatin A results in decreased expression of HIPK2 mRNA CTD PMID:27188386 trimellitic anhydride increases expression ISO RGD:1319650 6480464 trimellitic anhydride results in increased expression of HIPK2 mRNA CTD PMID:19042947 troglitazone increases expression ISO RGD:1319649 6480464 troglitazone results in increased expression of HIPK2 mRNA CTD PMID:19140230 troglitazone decreases expression ISO RGD:1319650 6480464 troglitazone results in decreased expression of HIPK2 mRNA CTD PMID:28973697 troglitazone increases expression ISO RGD:1319650 6480464 troglitazone results in increased expression of HIPK2 mRNA CTD PMID:12732648 valproic acid decreases methylation ISO RGD:1319649 6480464 Valproic Acid results in decreased methylation of HIPK2 gene CTD PMID:29154799 valproic acid affects splicing EXP 6480464 Valproic Acid affects the splicing of HIPK2 mRNA CTD PMID:29427782 valproic acid increases expression ISO RGD:1319650 6480464 Valproic Acid results in increased expression of HIPK2 mRNA CTD PMID:21427059 vinclozolin affects expression EXP 6480464 vinclozolin affects the expression of HIPK2 mRNA CTD PMID:19015723 vitamin E multiple interactions ISO RGD:1319649 6480464 [Selenium co-treated with Vitamin E] results in decreased expression of HIPK2 mRNA CTD PMID:19244175 vitamin E decreases expression ISO RGD:1319649 6480464 Vitamin E results in decreased expression of HIPK2 mRNA CTD PMID:19244175 vorinostat decreases expression ISO RGD:1319649 6480464 vorinostat results in decreased expression of HIPK2 mRNA CTD PMID:27188386 xylitol increases expression ISO RGD:1319649 6480464 Xylitol results in increased expression of HIPK2 mRNA CTD PMID:32275922 zinc dichloride multiple interactions ISO RGD:1319649 6480464 zinc chloride inhibits the reaction [cobaltous chloride inhibits the reaction [Doxorubicin promotes the reaction [HIPK2 protein binds to HIF1A promoter]]] more ... CTD PMID:19714248 zinc dichloride multiple interactions ISO RGD:1319650 6480464 [Doxorubicin co-treated with zinc chloride] results in increased expression of HIPK2 mRNA CTD PMID:19714248
